| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| LYT-200 | LYT-200 | Phase 2 Clinical | Puretech Health | Solid tumours; Head and Neck Neoplasms; Myelodysplastic Syndromes; Carcinoma, Transitional Cell; Pancreatic Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Leukemia, Myeloid, Acute; Neoplasm Metastasis | Details |